Cargando…

Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin

OBJECTIVES: Patient-reported symptoms correlate poorly with mucosal inflammation. Clinical decision-making may, therefore, not be based on objective evidence of disease activity. We conducted a study to determine factors associated with clinical decision-making in a secondary care inflammatory bowel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Derwa, Yannick, Williams, Christopher J.M., Sood, Ruchit, Mumtaz, Saqib, Bholah, M. Hassan, Selinger, Christian P., Hamlin, P. John, Ford, Alexander C., Gracie, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784497/ https://www.ncbi.nlm.nih.gov/pubmed/29383026 http://dx.doi.org/10.1177/1756283X17744739

Ejemplares similares

Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease
por: El-Matary, Wael, et al.
Publicado: (2017)

Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
por: Day, Andrew S., et al.
Publicado: (2017)

The Effect of Antidepressants on the Course of Inflammatory Bowel Disease
por: Hall, Barry J., et al.
Publicado: (2018)

Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the Past
por: Sood, Ruchit, et al.
Publicado: (2015)

High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment
por: Kane, John S., et al.
Publicado: (2018)

Calprotectin in inflammatory bowel disease
por: Khaki-Khatibi, Fatemeh, et al.
Publicado: (2020)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

Fatigue and its associated factors in microscopic colitis
por: Kane, John S., et al.
Publicado: (2018)

Patient education interventions for optimizing bowel cleansing before colonoscopy: is the juice worth the squeeze?
por: Mohammed, Noor, et al.
Publicado: (2015)

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
por: Lamb, C A, et al.
Publicado: (2011)

Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis
por: Cypers, H, et al.
Publicado: (2016)

Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn’s disease and ulcerative colitis
por: Bathe, Anna Luisa, et al.
Publicado: (2019)

The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009)

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases
por: Kapel, Nathalie, et al.
Publicado: (2023)

Calprotectin, Biomarker of Depression in Patients with Inflammatory Bowel Disease?
por: Iordache, Miorita Melina, et al.
Publicado: (2023)

Correlation of rapid point-of-care vs send-out fecal calprotectin monitoring in pediatric inflammatory bowel disease
por: Rodriguez, Alexis, et al.
Publicado: (2017)

Point-of-care faecal calprotectin testing in patients with paediatric inflammatory bowel disease during the COVID-19 pandemic
por: Jere, Mwansa, et al.
Publicado: (2021)

Randomized controlled trial: a pilot study of a psychoeducational intervention for fatigue in patients with quiescent inflammatory bowel disease
por: O’Connor, Anthony, et al.
Publicado: (2019)

Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy
por: Huang, Vivian W., et al.
Publicado: (2015)

Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease
por: Haisma, Sjoukje-Marije, et al.
Publicado: (2019)

The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
por: Lee, Yang Woon, et al.
Publicado: (2019)

Is fecal calprotectin always normal in children with irritable bowel syndrome?
por: Choi, You Jin, et al.
Publicado: (2019)

Prostaglandins and calprotectin are genetically and functionally linked to the Inflammatory Bowel Diseases
por: Karaky, Mohamad, et al.
Publicado: (2022)

Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
por: Mowat, Craig, et al.
Publicado: (2016)

Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease
por: Crawford, Erin, et al.
Publicado: (2021)

FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease
por: Rosenfeld, Greg, et al.
Publicado: (2016)

The comparison of the three assays for determination of fecal calprotectin in inflammatory bowel disease
por: Osredkar, Joško, et al.
Publicado: (2021)

Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?
por: Romero-Mascarell, Cristina, et al.
Publicado: (2022)

Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome
por: Campbell, James P., et al.
Publicado: (2021)

Endoscopy within 7 days after detecting high calprotectin levels can be useful for therapeutic decision-making in ulcerative colitis
por: Yong, Ho Min, et al.
Publicado: (2021)

The point of normative models in judgment and decision making
por: Baron, Jonathan
Publicado: (2012)

Utility of Intestinal Ultrasound in Clinical Decision-Making for Inflammatory Bowel Disease
por: Saleh, Adam, et al.
Publicado: (2023)

Usefulness of Faecal Calprotectin Measurement in Children with Various Types of Inflammatory Bowel Disease
por: Komraus, Marzena, et al.
Publicado: (2012)

Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease
por: Jang, Hui Won, et al.
Publicado: (2016)

From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
por: Mumolo, Maria Gloria, et al.
Publicado: (2018)

Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization
por: Fukunaga, Shuhei, et al.
Publicado: (2018)

Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease
por: Kittanakom, Saranya, et al.
Publicado: (2017)

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao, Ying, et al.
Publicado: (2021)

Intestinal Ultrasound Is the Ideal Patient-Centric, Point-of-Care Tool for Clinical Decision Making in the Inflammatory Bowel Disease Practice
por: Dolinger, Michael Todd, et al.
Publicado: (2023)

Does faecal calprotectin differentiate between inflammatory bowel disease colitis and non-inflammatory bowel disease colitides?
por: Khalil, Ahmed F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cvntrhpotih8sceacrpiu7khai